Cargando…
The pharmacokinetics of gabapentin in cats
BACKGROUND: Gabapentin is the most commonly prescribed medication for the treatment of chronic musculoskeletal pain in cats. Despite this common and chronic usage, clinically relevant pharmacokinetic data is lacking. OBJECTIVES: To evaluate the pharmacokinetics of clinically relevant dosing regimens...
Autores principales: | Adrian, Derek, Papich, Mark G., Baynes, Ronald, Stafford, Emma, Lascelles, B. Duncan X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271300/ https://www.ncbi.nlm.nih.gov/pubmed/30307652 http://dx.doi.org/10.1111/jvim.15313 |
Ejemplares similares
-
Clinical safety of robenacoxib in cats with chronic musculoskeletal disease
por: King, Jonathan N., et al.
Publicado: (2021) -
Posaconazole Pharmacokinetics in Healthy Cats after Oral and Intravenous Administration
por: Mawby, D.I., et al.
Publicado: (2016) -
A pilot study of transdermal gabapentin in cats
por: Slovak, Jennifer E., et al.
Publicado: (2021) -
Population pharmacokinetic analysis of enrofloxacin and its active metabolite ciprofloxacin after intravenous injection to cats with reduced kidney function
por: Foster, Jonathan D., et al.
Publicado: (2023) -
Ciprofloxacin Pharmacokinetics in Clinical Canine Patients
por: Papich, M.G.
Publicado: (2017)